What is ANI Pharmaceuticals's total equity?

ANI Pharmaceuticals (ANIP) reported total equity of $562.3M in Q1 2026.

How has ANI Pharmaceuticals's total equity changed year-over-year?

ANI Pharmaceuticals's total equity increased by 34.3% year-over-year, from $418.62M to $562.3M.

What is the long-term trend for ANI Pharmaceuticals's total equity?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's total equity has grown at a 22.5% compound annual growth rate (CAGR), from $195.7M to $540.72M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

ANI Pharmaceuticals ANIP Total Equity

Total Equity at other companies

Amneal Pharmaceuticals, Inc.AMRX

-$45.41M+65.5%

AnaptysBio, Inc.ANAB

$12.75M-62.5%

ALN

Alnylam PharmaceuticalsALNY

$1.08B+152%

Aurinia PharmaceuticalsAUPH

$567.63M+62.1%

AmgenAMGN

$9.19B+48.1%

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's total equity?: ANI Pharmaceuticals (ANIP) reported total equity of $562.3M in Q1 2026.
How has ANI Pharmaceuticals's total equity changed year-over-year?: ANI Pharmaceuticals's total equity increased by 34.3% year-over-year, from $418.62M to $562.3M.
What is the long-term trend for ANI Pharmaceuticals's total equity?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's total equity has grown at a 22.5% compound annual growth rate (CAGR), from $195.7M to $540.72M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.